 |
 |
 |
|
First-Line Antiretroviral Treatment Characteristics Among HIV-Infected Patients With and Without Comorbidities.....High Comorbidities Rates in 40 Year Old (SD-12) HIV+....."
|
|
|
"study findings support the need for clinicians to consider comorbidities when selecting ARV therapy in order to minimize drug-drug interactions and adverse events and thereby optimize treatment outcomes"
Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
Girish Prajapati, MBBS, MPH; Dongmu Zhang, PhD; Bridgett Goodwin, PhD
Merck & Co., Inc., Kenilworth, NJ, USA







|
|
|
 |
 |
|
|